4.2.3.5	(17beta)-17-(4-hydroxybenzoyl)androsta-3,5-diene-3-carboxylic acid	-	226139	
4.2.3.5	(2E)-5,7-dihydroxy-2-[[4-(pyrrolidin-1-yl)phenyl]methylidene]-1-benzofuran-3(2H)-one	-	228174	
4.2.3.5	(2E)-5,7-dihydroxy-2-[[4-(trifluoromethyl)phenyl]methylidene]-1-benzofuran-3(2H)-one	-	228173	
4.2.3.5	(2E)-6,7-dihydroxy-2-([2-hydroxy-4-[(6-hydroxyhexyl)oxy]phenyl]methylidene)-1-benzofuran-3(2H)-one	-	228175	
4.2.3.5	(3R,4R,5R)-5-(carboxymethoxy)-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85392	
4.2.3.5	(3R,4S,5R)-4-hydroxy-3-[(2S)-1-hydroxy-1-oxo-2-phosphonooxypropan-2-yl]oxy-5-phosphonooxycyclohexene-1-carboxylic acid	-	85393	
4.2.3.5	(3R,4S,5R)-5-(1-carboxyethoxy)-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85394	
4.2.3.5	(3R,4S,5R)-5-[(1R)-1-carboxy-1-phosphonoethoxy]-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85396	
4.2.3.5	(3R,4S,5S,6S)-5-(1-carboxyethenoxy)-6-fluoro-4-hydroxy-3-phosphonooxycyclohexene-1-carboxylic acid	-	85395	
4.2.3.5	(6R)-6-fluoro-5-enoylpyruvylshikimate 3-phosphate	IC50 is 0.0005 mM when the enzyme is preincubated with the inhibitor, the IC50 is 0.25 mM when the enzyme is not preincubated with the inhibitor, inhibition is not absolutely irreversible	54530